Lewes, DE -- (SBWIRE) -- 07/17/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: OncoSec Medical Inc (OTCMKTS:ONCS), FANNIE MAE PFD S (OTCBB:FNMAS), Arch Therapeutics Inc (OTCBB:ARTH), Globalstar, Inc. (OTCMKTS:GSAT)
OncoSec Medical Inc (OTCMKTS:ONCS) gained volume of 530,698 shares and the average volume of the stock remained 1.11 million shares. The 52 week range of the stock remained $0.17 - $0.49 and the day range was $0.28 - $0.30, recently. The stock opened the session at $0.29, and its recent trading price was $0.304. The stock showed a positive performance of 3.40% in its trading session. OncoSec Medical Incorporated is an emerging drug-medical device company. The Company focused on designing, developing and commercializing medical approaches for the treatment of solid cancers. In March 2011, the Company acquired from Inovio Pharmaceuticals, Inc. (Inovio) certain assets related to the use of drug-medical device combination products for the treatment of different cancers.
What was the Moving Force behind ONCS on Bullish Run? Read This Research Report
In the recent trading session, FANNIE MAE PFD S (OTCBB:FNMAS) traded 129,876 shares and the average volume of the stock remained 2.29 million shares. The 52 week range of the stock remained $0.46 - $6.90. The stock was a bull and advanced 1.19%, while its trading price stayed at $5.11. The market capitalization of the stock remained 1.41 billion. The half-yearly trend of the stock remained positive 171.81 %.
For How Long FNMAS will fight for Profitability? Read This Trend Analysis report
Arch Therapeutics Inc (OTCBB:ARTH) volume of the stock was 2.42 million shares in the most recent session and the average volume remained 1.40 million shares. The stock plunged -18.65% in its recent trading session, at the trading price of $0.580. Arch Therapeutics, Inc. (Arch), formerly Almah, Inc., operates as a life science company developing polymers containing peptides intended to form gel-like barriers over wounds to stop or control bleeding. Arch is a medical device company offering an approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care. Arch’s products are in preclinical development.
Has ARTH Found The Bottom and Ready To Move Up? Find Out Here
Globalstar, Inc. (OTCMKTS:GSAT) traded with volume of 2.03 million shares and the average volume of the stock remained 1.31 million shares. The stock grew 5.39% and was recently trading at $0.674. The market capitalization of the stock remained 332 million. The beta of the stock remained 3.53. Globalstar, Inc. (Globalstar) is a provider of mobile voice and data communications services globally via satellite. Globalstar’s satellite communications business, by providing critical mobile communications to the Company's subscribers, serves principally recreation and personal; government; public safety and disaster relief; oil and gas; maritime and fishing; natural resources, mining and forestry; construction; utilities and transportation.
For How Long GSAT Gloss will Attract Investors? Find out via this report
About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/